To determine the molecular mechanism underlying the oncogenic effect of PDEF on ER-negative BC cell proliferation, we analysed AR downstream intracellular signalling components, including MEK/ERK, PI3K/AKT and MYC/MAD1. This evidence concerns the gene AKT1 and breast cancer.